Application 125496
- Type
- BLA
- Sponsor
- JANSSEN BIOTECH
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125496 | Sylvant | siltuximab | 351(a) | Rx | 2026-06-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SYLVANT | SILTUXIMAB | INJECTABLE;INJECTION | 100MG | No | No |
| 002 | SYLVANT | SILTUXIMAB | INJECTABLE;INJECTION | 400MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sylvant | SILTUXIMAB | Recordati Rare Diseases, Inc. | 8d663642-f52e-49c0-a023-2da083fdfc0b | 2024-08-27 | Warnings, Adverse reactions | BLA125496 73090-420 73090-421 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 57894-420 | SYLVANT | siltuximab | Janssen Biotech, Inc. | BLA | Current |
| 57894-420 | SYLVANT | siltuximab | Janssen Biotech, Inc. | BLA | Current |
| 57894-421 | SYLVANT | siltuximab | Janssen Biotech, Inc. | BLA | Current |
| 57894-421 | SYLVANT | siltuximab | Janssen Biotech, Inc. | BLA | Current |
| 73090-420 | Sylvant | Siltuximab | EUSA Pharma (UK) Ltd | BLA | Current |
| 73090-420 | Sylvant | Siltuximab | EUSA Pharma (UK) Ltd | BLA | Current |
| 73090-420 | Sylvant | Siltuximab | EUSA Pharma (UK) Ltd | BLA | Current |
| 73090-420 | Sylvant | Siltuximab | EUSA Pharma (UK) Ltd | BLA | Current |
| 73090-421 | Sylvant | Siltuximab | EUSA Pharma (UK) Ltd | BLA | Current |
| 73090-421 | Sylvant | Siltuximab | EUSA Pharma (UK) Ltd | BLA | Current |
| 73090-421 | Sylvant | Siltuximab | EUSA Pharma (UK) Ltd | BLA | Current |
| 73090-421 | Sylvant | Siltuximab | EUSA Pharma (UK) Ltd | BLA | Current |